Evolus, Inc. - Common stock, par value $0.00001 per share (EOLS)

Historical Holders from Q1 2016 to Q1 2025

Symbol
EOLS on Nasdaq
CUSIP
30052C107
Type / Class
Equity / Common stock, par value $0.00001 per share
Shares outstanding
62.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
51.9M
Holdings value
$573M
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
163
Number of buys
71
Number of sells
-73
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evolus, Inc. - Common stock, par value $0.00001 per share (EOLS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.9% $52.5M 4.36M BlackRock, Inc. Dec 31, 2024
Nantahala Capital Management, LLC 4.48% $34M 2.82M Nantahala Capital Management, LLC Sep 30, 2024
Medytox Inc. 3.4% $25.7M 2.14M Medytox Inc. Dec 31, 2024

Institutional Holders of Evolus, Inc. - Common stock, par value $0.00001 per share (EOLS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 811K $9.75M +$2.88M $12.03 11
2024 Q4 51.9M $573M +$6.95M $11.04 163
2024 Q3 50.3M $815M -$14.8M $16.20 164
2024 Q2 51.3M $557M +$21.9M $10.85 157
2024 Q1 49.3M $691M +$47.4M $14.00 159
2023 Q4 43M $452M +$27.2M $10.53 147
2023 Q3 41.3M $378M +$40.4M $9.14 133
2023 Q2 37.1M $270M +$15.2M $7.27 129
2023 Q1 34.1M $289M +$41.9M $8.46 123
2022 Q4 29.1M $219M +$13.7M $7.51 113
2022 Q3 25.5M $205M -$5.1M $8.05 118
2022 Q2 25.1M $292M +$15.7M $11.60 113
2022 Q1 22.9M $256M +$24.9M $11.22 112
2021 Q4 20.5M $133M +$17.2M $6.51 100
2021 Q3 17.4M $133M +$1.93M $7.62 108
2021 Q2 16.2M $205M +$96.5M $12.65 109
2021 Q1 8.61M $112M +$17.8M $12.99 92
2020 Q4 6.24M $21M +$2.38M $3.36 75
2020 Q3 4.54M $18.1M -$10.3M $3.91 74
2020 Q2 7.89M $41.8M -$20.3M $5.30 75
2020 Q1 11.5M $47.5M -$12M $4.15 89
2019 Q4 14M $170M +$67.3M $12.17 100
2019 Q3 5.52M $86.3M +$6.51M $15.62 89
2019 Q2 5.28M $77.2M +$17.3M $14.62 100
2019 Q1 3.76M $84.8M -$5.15M $22.57 87
2018 Q4 5.41M $64.3M -$25.5M $11.90 71
2018 Q3 6.64M $124M +$57.7M $18.62 66
2018 Q2 3.52M $98.6M +$802K $27.99 54
2018 Q1 4.45M $40.1M +$40.1M $9.03 39
2016 Q1 12.8K $286K $0 $22.41 1